TY - JOUR
T1 - Variations in Nutrition Practices in Cystic Fibrosis
T2 - A Survey of the DIGEST Program
AU - Shaikhkhalil, Ala K.
AU - Freeman, Alvin J.
AU - Sathe, Meghana
N1 - Publisher Copyright:
© 2020 American Society for Parenteral and Enteral Nutrition
PY - 2021/12
Y1 - 2021/12
N2 - Background: Evidence-based management of gastrointestinal (GI) and nutrition manifestations of cystic fibrosis (CF) is limited, and practice variations have not been studied. Methods: Thus, a survey was developed with the purpose of evaluating current nutrition practices of CF-focused gastroenterologists, specifically utilizing awardees and mentors of the Cystic Fibrosis Foundation (CFF) Developing Innovative GastroEnterology Specialty Training (DIGEST) Program. Topics included appetite stimulation, tube feeding (TF), and aspects of nutrition assessment, specifically urine sodium and essential fatty acid (EFA) status. Results: The response rate was 61% (22/36). About half (55%; 12/22) of respondents had 5–10 years of experience in GI, and 23% (5/22) had >10 years. In regard to appetite stimulation, the majority used cyproheptadine; however, duration and pattern of prescribing varied. Variation was noted in TF management pertaining to tube placement, formula choice, and prescribing pancreatic enzyme replacement therapy with overnight TF. The majority did not check EFAs or urine sodium. Treatment for deficiencies in EFA or abnormal urine sodium was inconsistent. Conclusion: The survey reveals wide variation in management of some aspects of nutrition-related manifestations of CF among experienced providers. This reflects the need for research to provide evidence-based guidelines.
AB - Background: Evidence-based management of gastrointestinal (GI) and nutrition manifestations of cystic fibrosis (CF) is limited, and practice variations have not been studied. Methods: Thus, a survey was developed with the purpose of evaluating current nutrition practices of CF-focused gastroenterologists, specifically utilizing awardees and mentors of the Cystic Fibrosis Foundation (CFF) Developing Innovative GastroEnterology Specialty Training (DIGEST) Program. Topics included appetite stimulation, tube feeding (TF), and aspects of nutrition assessment, specifically urine sodium and essential fatty acid (EFA) status. Results: The response rate was 61% (22/36). About half (55%; 12/22) of respondents had 5–10 years of experience in GI, and 23% (5/22) had >10 years. In regard to appetite stimulation, the majority used cyproheptadine; however, duration and pattern of prescribing varied. Variation was noted in TF management pertaining to tube placement, formula choice, and prescribing pancreatic enzyme replacement therapy with overnight TF. The majority did not check EFAs or urine sodium. Treatment for deficiencies in EFA or abnormal urine sodium was inconsistent. Conclusion: The survey reveals wide variation in management of some aspects of nutrition-related manifestations of CF among experienced providers. This reflects the need for research to provide evidence-based guidelines.
KW - appetite
KW - cystic fibrosis
KW - enteral nutrition
KW - essential fatty acids
KW - gastrointestinal tract
KW - nutrition assessment
KW - surveys and questionnaires
KW - urine sodium
UR - http://www.scopus.com/inward/record.url?scp=85096720067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096720067&partnerID=8YFLogxK
U2 - 10.1002/ncp.10605
DO - 10.1002/ncp.10605
M3 - Article
C2 - 33242217
AN - SCOPUS:85096720067
SN - 0884-5336
VL - 36
SP - 1247
EP - 1251
JO - Nutrition in Clinical Practice
JF - Nutrition in Clinical Practice
IS - 6
ER -